COVID-19 in Pediatric Granulomatosis with Polyangiitis

Amir Saeed; Eslam Shorafa; Zahra Seratishirazi; Seyedenarjes Abootalebi

doi:10.3390/pediatric13010004

COVID-19 in Pediatric Granulomatosis with Polyangiitis

Pediatr Rep. 2021 Jan 4;13(1):31-34. doi: 10.3390/pediatric13010004.

Authors

Amir Saeed¹, Eslam Shorafa¹, Zahra Seratishirazi¹, Seyedenarjes Abootalebi¹

Affiliation

¹ Department of Pediatrics, Division of Intensive Care Unit, Shiraz University of Medical Sciences, Shiraz 71348, Iran.

Abstract

The confirmed cases with COVID-19 in children account for just 1% of the overall confirmed cases. Severe COVID-19 in children is rare. Case Presentation: Our patient was 16 years old with a severe case of COVID-19 and did not survive due to the presence of Granulomatosis with polyangiitis and being treated with immunosuppressive drugs. We used lopinavir, ritonavir, hydroxy chloroquine, intravenous immunoglobulin and continuous veno-venous hemodialysis for treatment. Conclusion: In this patient, an underlying disease and delayed admission to the hospital were two factors complicating his condition.

Keywords: COVID19; coronavirus; granulomatosis with polyangiitis; wegener.

Publication types

Case Reports